 |
|
 |
- September 3, 2010 |
|
|
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.
CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
|
|
|
| Presentation |
|
"1st International Congress on “Prediabetes” and the Metabolic Syndrome – A Review"Prof. Timothy Davis (biography)
English - 2005-04-15 - 38 minutes
|
 | (22 slides) |
Summary :
In this presentation Prof. Davis gives an overview of salient conclusions presented at the 1st International Congress on “Prediabetes” and the Metabolic Syndrome held in Berlin, Germany from April 13th-16th, 2005.
The term “prediabetes” has previously been used in a retrospective sense to describe the period preceding the diagnosis of diabetes, but now has come to mean IFG or IGT or both. Prof. Davis discusses the prevalence of IFG and IGT, and the increased risk of macrovascular disease associated with prediabetes beginning within the euglycaemic range.
The new IDF consensus on the metabolic syndrome was another major topic of interest. The IDF consensus meeting of 2004 aimed to come up with a practical definition of the metabolic syndrome, and the resulting consensus definition incorporates ethnic-specific cutoff values for waist circumference as a measure of central adiposity, and some other new features and considerations.
Different studies have investigated the prevention of diabetes in prediabetic subjects with lifestyle modification and/or pharmacological agents. Important conclusions from the U.S. DPP and Indian Diabetes Prevention Programme (IDPP), Finnish DPS and STOP-NIDDM trials are discussed, as well as the HHS, VAHIT and BIP studies which looked at the effects of fibrates in patients with the metabolic syndrome.
Prof. Davis gives an overview of ongoing intervention studies in subjects with prediabetes or diabetes plus at least one other CVD risk factor, and a recap of presentations on the health economic aspects of treating the metabolic syndrome. Finally, recent studies point to the importance of acute hyperglycaemia in predicting short- and long-term outcomes after acute myocardial infarction, and hence a need for strict glycaemic control following the event.
Copyright © 2005 E-MedHosting.com Inc.
Learning objectives :
After viewing this presentation the participant will be able to discuss:
- “Prediabetes” - definition and associated increased risk of macrovascular disease;
- Definition of the metabolic syndrome: New IDF Consensus;
- Treatment of the metabolic syndrome;
- Current intervention studies in people with prediabetes or diabetes plus at least one other CVD risk factor;
- Health economic aspects of treating the metabolic syndrome;
- Importance of acute hyperglycaemia as a determinant of short- and long-term outcomes post-AMI.
|
|
|
|
|
|
| Search our website |
 |
| |
Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes. |
| |
|
|
| Social |
|
| |
Let others know about this presentation.
|
|
|
|
